Intera Atlas
Run match
Sites / Global Health Research Center
Is this you?

Request access for Global Health Research Center with your @globalhealthrcenter.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Global Health Research Center

Unclaimed profile

Site Network · Hialeah/Miami Lakes, FL · ~3 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 4Lift (cardio sample) 0.36Recruit soph 0.14
Quality Scorecard (1–100)
Overall80Recruit68Ops80Sponsor93Ther85

Performance (observed)

Historical trials
614
Completed
324
Terminated/Withdrawn
85
Completion rate
79%
Active now
194
Phase 2
177
Phase 3
370
Realized enrollment
879,067
First study year
2001
Years active
25
Match confidence
high
Enrollment velocity (inf)
35,163

Therapeutic

Areas
Atopic dermatitis, COVID-19 (treatment/vaccine studies), Influenza vaccine, Type 2 diabetes/weight loss, Phase I-IV
Specialties
Atopic dermatitis, COVID-19 treatments/vaccines, influenza vaccines, type 2 diabetes (weight loss)
Breadth (conditions)
543
States
FL

Recruitment (web observed)

Advertises recruitment
Yes
Capability notes
Multi-site enrollment focus; dermatology and metabolic/infectious disease specialization; Florida regional patient base

Relationships

Sponsors
Pfizer; Boehringer Ingelheim; Merck Sharp & Dohme LLC; Hoffmann-La Roche; AbbVie; Eli Lilly and Company
CROs
Fortrea; ICON plc; IQVIA Pty Ltd; PRA Health Sciences; Premier Research; Teva Branded Pharmaceutical Products R&D LLC
Owner / parent
Private (family-operated; 30+ combined years experience; established 2012)

Capacity & people

Investigators
—
Coordinators
—
CEO
Unknown (President per LinkedIn - family-operated)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
globalhealth@globalhealthrcenter.com

Tech & DCT

DCT / decentralized
Y - multi-site (Miami Lakes, Tampa, Orlando, FL)
Recruiting visible
Y

Notes

Small family-operated multi-site network (3 FL locations) with recruitment focus and practical investigator team. Established 2012 in Miami Lakes; expanded to Tampa/Orlando 2021 & 2024. Infectious disease/vaccine experience (COVID-19 vaccines) + metabolic disease (diabetes/weight loss) shows breadth. Limitations: Geographic constraint (FL only, 3 sites); family operation may limit institutional buyer confidence/scalability; no AI/modern tech stack disclosed; modest growth trajectory over 14 years. Reasonable community SMO but limited Intera fit due to scale and geographic/operational constraints. Better as local/regional partner than national platform. [Validated: 5 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.36Overall80

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.